HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,257-2,268 of 4,505
Drug study icon
CompletedNCT00821600

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of people with Schizophrenia

Official study title

Single-Dose, Open-Label Pilot Study to Explore the Pharmacokinetics, Safety and Tolerability of a Gluteal Intramuscular Injection of a 4-Week Long-Acting Injectable Formulation of Risperidone in Patients With Chronic Stable Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00071747

Clinical Study Of Schizophrenia in Both Men and Women

What is this study about?

This study evaluated the effectiveness of lamotrigine for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
GlaxoSmithKline
Other study type icon
CompletedNCT01674543

Clinical Symptoms of Schizophrenia and Physical Exercise

Official study title

Schizophrenia and Physical Exercise: Effect of 20 Weeks of Training in Symptoms and Concentration in Serum IGF-1 and BDNF

This study has finished and is no longer accepting participants.

In São Paulo
SchizophreniaInterventional studyAges 18–50
Countries
Brazil
Sponsor
Federal University of São Paulo
Drug study icon
CompletedNCT02832037

study of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Official study title

A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–50
Countries
United States, Canada, United Kingdom, + 8 others
Sponsor
Boehringer Ingelheim
Drug study icon
TerminatedNCT00044083

study of Tolcapone for Cognition in Schizophrenia

Official study title

Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype

This study ended early.

In Bethesda
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT01639872

Clozapine for Cannabis Use in Schizophrenia

What is this study about?

Researchers compared Clozapine and Risperidone to find out how the approaches affected cannabis use in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.